Cogent Biosciences Inc
(COGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 83,355 | 75,582 | 74,933 | 73,734 | 75,414 |
| Operating Income | -83,355 | -75,582 | -74,933 | -73,734 | -75,414 |
| Interest Expense | 1,459 | 314 | 0 | 0 | 0 |
| Other Income | 3,884 | 2,367 | 2,947 | 5,807 | 4,780 |
| Pre-tax Income | -80,930 | -73,529 | -71,986 | -67,927 | -70,634 |
| Net Income Continuous | -80,930 | -73,529 | -71,986 | -67,927 | -70,634 |
| Net Income | $-80,930 | $-73,529 | $-71,986 | $-67,927 | $-70,634 |
| EPS Basic Total Ops | -0.50 | -0.53 | -0.52 | -0.50 | -0.52 |
| EPS Basic Continuous Ops | -0.59 | -0.64 | -0.64 | -0.61 | -0.64 |
| EPS Diluted Total Ops | -0.50 | -0.53 | -0.52 | -0.50 | -0.52 |
| EPS Diluted Continuous Ops | -0.59 | -0.64 | -0.64 | -0.61 | -0.64 |
| EPS Diluted Before Non-Recurring Items | -0.50 | -0.53 | -0.52 | -0.09 | -0.64 |
| EBITDA(a) | $-82,581 | $-74,648 | $-75,248 | $-75,713 | $-80,994 |